Coronavirus disease (COVID-19) is an infectious disease caused by the most recently discovered corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, and difficulty breathing. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elderly people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The COVID-19 virus is primarily transmitted through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. People can catch COVID-19 if they breathe in droplets from a person with COVID-19 who coughs out or exhales droplets. It also spreads when a person touches a surface or objects that has the virus on it, and then touches their eyes, nose, or mouth.
DelveInsight’s, “COVID-19 Pipeline Insight, 2021” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in COVID-19 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/covid-19-coronavirus-pipeline-insights
Some of the COVID-19 Companies are:
- Vir Biotechnology/ GlaxoSmithKline
- Can-Fite Biopharma
- AbbVie
- Novartis
- Tonix Pharmaceuticals
- Molecular Partners
- Veru Inc.
- PTC Therapeutics
- RedHill Biopharma
- SAb Biotherapeutics
- Adagio Therapeutics
- Valneva
- Novavax
- Inovio Pharmaceuticals
- VBI Vaccines
- Rigel Pharmaceuticals
- Translate Bio
- Evelo Biosciences
- Cocrystal Pharma
- Icosavax
- Atea Pharmaceuticals
- NovaLead
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/covid-19-coronavirus-pipeline-insights
DelveInsight’s COVID-19 report covers around 200+ products under different phases of clinical development like:
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage products (Phase I/II and Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Some of COVID-19 Therapies are:
- Sotrovimab
- CF-101
- ABBV-47D11
- MAS-825
- TNX 1800
- MP-0420
- MP0423
- VERU-111
- PTC-299
- RHB-107
- SAB-185
- ADG20
- VLA2001
- NVX-CoV2373
- INO-4800
- VBI-2902
- Fostamatinib
- MRT5500
- EDP-1815
- CDI-45205
- IVX-411
- AT‐527
- NLP21
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/covid-19-coronavirus-pipeline-insights
Current COVID-19 Treatment Scenario and COVID-19 Emerging Therapies:
- How many companies are developing COVID-19 drugs?
- How many COVID-19 drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for COVID-19?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the COVID-19 therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for COVID-19 and their status?
- What are the key designations that have been granted to the emerging drugs?
Request for Free Sample Report: https://www.delveinsight.com/sample-request/covid-19-coronavirus-pipeline-insights
Table of Contents:
Introduction
Executive Summary
COVID-19: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
COVID-19– DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
• COVID-19 companies’ collaborations, Licensing, Acquisition -Deal Value Trends
COVID-19 Collaboration Deals
Late Stage Products (Phase III)
• Comparative Analysis
VERU-111: Veru Inc.
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
CF-101: Can-Fite Biopharma
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
• Comparative Analysis
ABBV-47D11: AbbVie
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
• Comparative Analysis
TNX-1800: Tonix Pharmaceuticals
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
COVID-19 Key Companies
COVID-19 Key Products
COVID-19- Unmet Needs
COVID-19- Market Drivers and Barriers
COVID-19- Future Perspectives and Conclusion
COVID-19 Analyst Views
COVID-19 Key Companies
Appendix
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/covid-19-coronavirus-pipeline-insights